Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2025-12-25 @ 9:26 PM
Study NCT ID:
NCT01194856
Status:
TERMINATED
Last Update Posted:
2017-08-11
First Post:
2010-09-02
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression
Sponsor:
The Cleveland Clinic
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
10-418
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None